Skip to contentA
Axogen, Inc.
A
AXGNAxogen, Inc. Q3 2014 · 10-Q
Revenue$4.67M$4.67M+58.0% vs Q3 2013 Net Income-$3.24M-$3.24MN/M vs Q3 2013 EPS Diluted-$0.19-$0.19N/M vs Q3 2013 Gross Profit$3,775,162+63.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,299,486N/M Free Cash Flowderived-$2,358,885N/M Margins · derivedGross margin80.8%+2.8 pt vs Q3 2013
Operating margin-38.6%+38.4 pt vs Q3 2013
Net margin-69.3%+50.8 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 13, 2014 · 44 d after period end